JANAE NILGES: Open Payments
NPI 1295327302 · HOLTON, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$314 in 17 payments from 9 companies in 2025. Trend: 2023 $283 · 2024 $186 · 2025 $314
Food & beverage: $314
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $110 |
| Lilly USA, LLC | 2 | $38 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $31 |
| Novo Nordisk Inc | 2 | $31 |
| Viatris Specialty LLC | 1 | $28 |
| Supernus Pharmaceuticals, Inc. | 1 | $26 |
| ABBVIE INC. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
| Electromed, Inc. | 1 | $14 |
Products named: LEQVIO, MOUNJARO, YUPELRI, Qelbree, UBRELVY, Ozempic, Wegovy, CAPLYTA.
Industry payments across KS — which companies pay providers there.
